glp-1 los altos La evidencia es clara: al suspender agonistas GLP-1, el rebote metabólico es real, consistente y clínicamente relevante, especialmente en obesidad. No se trata de falta de adherencia ni de voluntad. Se trata 1 supplement supports weight management. Mission Zero Net Carbs Original
Description
PMC5550996 Kato M, et al
The product has not been evaluated by the FDA for safety or effectiveness
The GLP-1 journey did not stop at treating Type 2 diabetes alone but has moved on to treating obesity, typically using higher dosing
Early research in rodents suggested a potential link between GLP-1 receptor agonists and thyroid C-cell tumours (medullary thyroid carcinoma)
References [1] Roche data on file
The FDA approval for Zepbound covers two distinct indications: For chronic weight management BMI of 30 or higher (clinical obesity), regardless of other health conditions
